Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22

Oncogene

Volumn 30, Issue 11, 2011, Pages 1290-1301

  Patel, J B ^a   Appaiah, H N ^a   Burnett, R M ^a   Bhat Nakshatri, P ^a   Wang, G ^a   Mehta, R ^a   Badve, S ^a   Thomson, M J ^b   Hammond, S ^c   Steeg, P ^d   Liu, Y ^a   Nakshatri, H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

breast cancer; let 7; metastasis; microRNA; miR 22

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 22; ONCOPROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADRENAL METASTASIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; EVI 1 GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENES; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS;

MUS MUSCULUS;

EID: 79952742813     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.510     Document Type: Article

References (48)

1. Bhat-Nakshatri P, Campbell RA, Patel NM, Newton TR, King AJ, Marshall MS et al. (2004). Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepres-sion function. Br J Cancer 90: 853-859. (Pubitemid 38406597)
2. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS et al. (2009). Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861.
3. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ et al. (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype. Genome Biol 8: R214.
4. Campbell MR, Amin D, Moasser MM. (2010). HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy. Clin Cancer Res 16: 1373-1383.
5. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P et al. (2009). The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106: 15732-15737.
6. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
7. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. (2007). NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724. (Pubitemid 46204250)
8. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B et al. (2007). Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANS-BIG multicenter independent validation series. Clin Cancer Res 13: 3207-3214. (Pubitemid 46944903)
9. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, Petrocca F et al. (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4: e7181.
10. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM. (2006). Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215-15226. (Pubitemid 43855111)
11. Friedl P, Wolf K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374. (Pubitemid 37328856)
12. Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ et al. (2009). Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 23: 2140-2151.
13. Goyama S, Nitta E, Yoshino T, Kako S, Watanabe-Okochi N, Shimabe M et al. (2010). EVI-1 interacts with histone methyl-transferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia 24: 81-88.
14. Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L et al. (2008). Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100: 1092-1103.
15. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C et al. (2005). Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 70: 149-158. (Pubitemid 44124866)
16. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. (2010). An online survival analysis tool to rapidly assess the effect of 22 277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat 123: 725-731.
17. Helbig G, Christopherson II KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638. (Pubitemid 36792563)
18. Hoser M, Baader SL, Bosl MR, Ihmer A, Wegner M, Sock E. (2007). Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia. J Neurosci 27: 5495-5505. (Pubitemid 46790178)
19. Hurst DR, Edmonds MD, Welch DR. (2009). Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495-7498.
20. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon GJ. (2007). A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 21: 3238-3243. (Pubitemid 350277751)
21. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. (2008). Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 3: e3740.
22. Inui M, Martello G, Piccolo S. (2010). MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
23. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549. (Pubitemid 36808649)
24. Koshiol J, Wang E, Zhao Y, Marincola F, Landi MT. (2010). Strengths and limitations of laboratory procedures for microRNA detection. Cancer Epidemiol Biomarkers Prev 19: 907-911.
25. Kumano K, Kurokawa M. (2010). The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells. J Cell Physiol 222: 282-285.
26. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
27. Liu Y, Chen L, Ko TC, Fields AP, Thompson EA. (2006). Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene 25: 3565-3575. (Pubitemid 43901678)
28. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Benes V et al. (2009). Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 69: 8332-8340.
29. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK et al. (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24.
30. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550-13555. (Pubitemid 41420886)
31. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG et al. (2010). A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 24: 447-463.
32. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. (2009). MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302.
33. O'Day E, Lal A. (2010). MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.
34. Pandey DP, Picard D. (2009). miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29: 3783-3790.
35. Ramaswamy S, Ross KN, Lander ES, Golub TR. (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54. (Pubitemid 36068681)
36. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A et al. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121-132. (Pubitemid 43202662)
37. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H et al. (2008). The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68: 5405-5413.
38. Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM et al. (2007). Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 445: 437-441. (Pubitemid 46160912)
39. Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, Imai Y et al. (2009). Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells. Oncogene 28: 4364-4374.
40. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J et al. (2006). Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272. (Pubitemid 43264710)
41. Steeg PS. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904. (Pubitemid 44175140)
42. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. (2008). Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-473. (Pubitemid 351482129)
43. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
44. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
45. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B et al. (2008). Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
46. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679. (Pubitemid 40260888)
47. Wieser R. (2007). The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene 396: 346-357. (Pubitemid 46935408)
48. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.